Boston Scientific Corp (NYSE:BSX)

27.20
Delayed Data
As of Feb 16
 +0.11 / +0.41%
Today’s Change
23.29
Today|||52-Week Range
29.93
+9.72%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Operating ActivitiesNet Income / Starting Line----------
Funds From Operations----------
Funds From/For Other Operating Expenses----------
Net Cash Flow - Operating Activities114.0M185.0M255.0M--
 
 
 
 
 
InvestingIncrease In Investments0.00-47.0M-42.0M--
 
 
 
Capital Expenditures-112.0M-68.0M-60.0M--
 
 
 
 
Other Investing - Uses-28.0M28.0M0.00--
 
 
 
Net Cash Flow Investing-140.0M-479.0M-102.0M--
 
 
 
 
 
FinancingShort Term Borrowings----240.0M--
 
 
Long Term Borrowings1.0B1.1B0.00--
 
 
 
Long Term Debt Reduction-985.0M-1.8B-400.0M--
 
 
 
 
Net Proceeds Stock Sale33.0M11.0M35.0M--
 
 
 
 
Common Preferred Redeemed0.000.000.00----
Common Dividends----------
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing----------
Other Uses - Financing79.0M1.0M14.0M--
 
 
 
 
Net Cash Flow - Financing-15.0M332.0M-139.0M--
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash1.0M1.0M1.0M--
 
 
 
 
 
Net Change In Cash-41.0M38.0M14.0M0.00